Canakinumab Subcutaneous and Lomotil (Diphenoxylate and Atropine Tablets)
Determining the interaction of Canakinumab Subcutaneous and Lomotil (Diphenoxylate and Atropine Tablets) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: atropine / diphenoxylate
Brand name: Lomotil, Lonox, Lomocot, Vi-Atro
Synonyms: Lomotil
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Lomustine
- Canakinumab Subcutaneous-Long Lasting Nasal Spray
- Canakinumab Subcutaneous-Lonhala Magnair
- Canakinumab Subcutaneous-Lonhala Magnair Starter Kit inhalation
- Canakinumab Subcutaneous-Loniten
- Canakinumab Subcutaneous-Lonox
- Lomotil (Diphenoxylate and Atropine Tablets)-Canasa
- Lomotil (Diphenoxylate and Atropine Tablets)-Canasa Pac rectal
- Lomotil (Diphenoxylate and Atropine Tablets)-Canasa rectal
- Lomotil (Diphenoxylate and Atropine Tablets)-Cancidas
- Lomotil (Diphenoxylate and Atropine Tablets)-Candesartan
- Lomotil (Diphenoxylate and Atropine Tablets)-Candesartan and Hydrochlorothiazide